Meyka Pro banner
Biofrontera Inc.

Biofrontera Inc. (BFRIW) Stock Overview

Explore Biofrontera Inc.’s financial performance, market position, analyst ratings, and future outlook.

BFRIWNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.04
$0.02(77.72%)
U.S. Market is Open · 15:54

Biofrontera Inc. (BFRIW)

Meyka AI Score

Z

Key Financials

Market Cap24.7M
P/E Ratio-0.95
EPS (TTM)$-1.12
ROE-4.77%
Fundamental Analysis

AI Price Forecasts

1 Month$0.04
3 Months$0.01
1 Year Target$0.86

BFRIW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biofrontera Inc. (BFRIW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.95 and a market capitalization of 24.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
77.23%
5-Day Change
61.26%
1-Month Change
14.01%
3-Month Change
-43.17%
6-Month Change
-31.15%
Year-to-Date (YTD) Change
-60.22%
1-Year Change
-63.13%
3-Year Change
-74.43%
5-Year Change
-97.22%
All-Time (Max) Change
-97.22%

Contact Information

781-245-1325
120 Presidential Way, Woburn, MA, 01801

Company Facts

920 Employees
IPO DateOct 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions